Image

Health Education Approach to Lung Screening

Health Education Approach to Lung Screening

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Description

This is a single-arm study of a patient navigation intervention to increase access to lung cancer screening (LCS).

Eligibility

Inclusion Criteria:

  • Meets current USPSTF guidelines for lunc cancer screening (LCS)
  • 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
        One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a
        year.
          -  Currently smokes or has quit smoking within the past 15 years
          -  Identifies as Black or African-American Note: Both Hispanic/Latino and
             Non-Hispanic/Latino patients are eligible as long as they also identify as Black or
             African-American (eg, Afro-Latino).
          -  Willing to complete all navigation-related study activities
          -  Able to understand and the willingness to sign a written informed consent document
        Exclusion Criteria:
        A patient who meets any of the following exclusion criteria is ineligible to participate in
        the study:
          -  Known history of cancer (except squamous cell skin cancer), chronic obstructive
             pulmonary disease (COPD), emphysema, or coughing up blood in the past 5 years, as
             reported by the individual
          -  Inability to speak English
          -  Medical, psychological, or social condition that, in the opinion of the investigator,
             may increase the patient's risk or limit the patient's adherence with study
             requirements

Study details
    Lung Cancer

NCT06070870

Virginia Commonwealth University

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.